Nicholas Basta

Industry is gearing up for another go at e-pedigree and anti-counterfeiting safeguards.

Do Dendreon’s troubles with over-optimistic sales forecasts put a cap on the promise of personalized medicine?

Satellite and cellular technologies, combined with advanced electronic sensors are creating new options for pharma shippers

The recent PDA Cold Chain conference highlighted increased regulatory scrutiny of shipping processes, even while logistics capacity and technology expand

GHX, a major player in med-surg supply management for healthcare providers, looks to extend its e-commerce platform to handling pharma e-pedigrees

While all the market indicators point to healthy growth, managing the CMO relationship is a challenge. Industry collaboration might fill in the regulatory gap

Industry and regulators are taking steps to revolutionize the basic regulatory function of collecting and analyzing adverse medical events

EDI use is slowly increasing, while GS1 standards compliance is skimpy

The implementation, executed with IT vendor Axway, has shaved nearly 18 days off order cycle times

MCM is but one way to get a focus on the explosive growth of new communication channels to physicians and patients

More pieces for industry-wide track-and-trace are falling into place, but there’s no rush to authenticate products

The seemingly routine process of identifying and locating prescribing physicians is becoming a critical industry function

Record numbers of attendees and exhibitors came together at Philadelphia meeting

As IT vendors leap into cloud computing, clients in life sciences struggle to keep the data flowing through the organizations

Research group finds ‘bad practices’ in current implementations as market grows to $8.5 billion

Court rulings begin to swing toward categorizing pharma reps as hourly workers

Dramatic traffic downturn makes providers more eager to offer service options; meanwhile, TSA 100% inspection rule looms for air carriers

By fits and starts, pharma and healthcare providers are moving ahead on IT technologies to layer track-and-trace capabilities on supply chains

The growing number of states with laws now are joined by the “51st state”: the federal government

The types of delivery mechanisms that vary the uptake of a drug are multiplying

The biopharma company’s annual report provides clarity to a confusing marketplace

‘Revenue Management’ Comes to the Rescue of Pharma’s Complex Pricing Environment

Faster-than-average growth of biologics, more global trade to emerging countries, and widening regulatory requirements will propel the activity